U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07765706) titled 'A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in Healthy Participants' on Aug. 10.
Brief Summary: The primary objective of this study is to assess the safety and tolerability of single and multiple ascending doses of INS1033 in healthy participants.
Study Start Date: Aug. 25
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: INS1033
Oral solution
DRUG: Placebo
Oral solution
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Insmed Incorporated
Published by HT Digital Content Services with permission from Health Daily Digest....